Clinical relevance of molecular identification of microorganisms and detection of antimicrobial resistance genes in bloodstream infections of paediatric cancer patients

Detalhes bibliográficos
Autor(a) principal: Carlesse, Fabianne [UNIFESP]
Data de Publicação: 2016
Outros Autores: Cappellano, Paola [UNIFESP], Quiles, Milene Goncalves [UNIFESP], Menezes, Liana Carballo [UNIFESP], Petrilli, Antonio Sergio [UNIFESP], Pignatari, Antonio Carlos [UNIFESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://repositorio.unifesp.br/handle/11600/51128
http://dx.doi.org/10.1186/s12879-016-1792-8
Resumo: Background: Bloodstream infections (BSIs) are the major cause of mortality in cancer patients. Molecular techniques are used for rapid diagnosis of BSI, allowing early therapy and improving survival. We aimed to establish whether real-time quantitative polymerase chain reaction (qPCR) could improve early diagnosis and therapy in paediatric cancer patients, and describe the predominant pathogens of BSI and their antimicrobial susceptibility. Methods: Blood samples were processed by the BACTEC system and microbial identification and susceptibility tests were performed by the Phoenix system. All samples were screened by multiplex 16 s rDNA qPCR. Seventeen species were evaluated using sex-specific TaqMan probes and resistance genes blaSHV, blaTEM, blaCTX, blaKPC, blaIMP, blaSPM, blaVIM, vanA, vanB and mecA were screened by SYBR Green reactions. Therapeutic efficacy was evaluated at the time of positive blood culture and at final phenotypic identification and antimicrobial susceptibility results. Results: We analyzed 69 episodes of BSI from 64 patients. Gram-positive bacteria were identified in 61 % of the samples, Gram-negative bacteria in 32 % and fungi in 7 %. There was 78.2 % of agreement between the phenotypic and molecular methods in final species identification. The mecA gene was detected in 81.4 % of Staphylococcus spp., and 91.6 % were concordant with the phenotypic method. Detection of vanA gene was 100 % concordant. The concordance for Gram-negative susceptibilities was 71.4 % for Enterobacteriaceae and 50 % for Pseudomonas aeruginosa. Therapy was more frequently inadequate in patients who died, and the molecular test was concordant with the phenotypic susceptibility test in 50 %. Conclusions: qPCR has potential indication for early identification of pathogens and antimicrobial resistance genes from BSI in paediatric cancer patients and may improve antimicrobial therapy.
id UFSP_f39ecff928d8b759720877b817d61801
oai_identifier_str oai:repositorio.unifesp.br:11600/51128
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Carlesse, Fabianne [UNIFESP]Cappellano, Paola [UNIFESP]Quiles, Milene Goncalves [UNIFESP]Menezes, Liana Carballo [UNIFESP]Petrilli, Antonio Sergio [UNIFESP]Pignatari, Antonio Carlos [UNIFESP]2019-07-22T15:46:52Z2019-07-22T15:46:52Z2016Bmc Infectious Diseases. London, v. 16, p. -, 2016.1471-2334http://repositorio.unifesp.br/handle/11600/51128http://dx.doi.org/10.1186/s12879-016-1792-8WOS000382744900003.pdf10.1186/s12879-016-1792-8WOS:000382744900003Background: Bloodstream infections (BSIs) are the major cause of mortality in cancer patients. Molecular techniques are used for rapid diagnosis of BSI, allowing early therapy and improving survival. We aimed to establish whether real-time quantitative polymerase chain reaction (qPCR) could improve early diagnosis and therapy in paediatric cancer patients, and describe the predominant pathogens of BSI and their antimicrobial susceptibility. Methods: Blood samples were processed by the BACTEC system and microbial identification and susceptibility tests were performed by the Phoenix system. All samples were screened by multiplex 16 s rDNA qPCR. Seventeen species were evaluated using sex-specific TaqMan probes and resistance genes blaSHV, blaTEM, blaCTX, blaKPC, blaIMP, blaSPM, blaVIM, vanA, vanB and mecA were screened by SYBR Green reactions. Therapeutic efficacy was evaluated at the time of positive blood culture and at final phenotypic identification and antimicrobial susceptibility results. Results: We analyzed 69 episodes of BSI from 64 patients. Gram-positive bacteria were identified in 61 % of the samples, Gram-negative bacteria in 32 % and fungi in 7 %. There was 78.2 % of agreement between the phenotypic and molecular methods in final species identification. The mecA gene was detected in 81.4 % of Staphylococcus spp., and 91.6 % were concordant with the phenotypic method. Detection of vanA gene was 100 % concordant. The concordance for Gram-negative susceptibilities was 71.4 % for Enterobacteriaceae and 50 % for Pseudomonas aeruginosa. Therapy was more frequently inadequate in patients who died, and the molecular test was concordant with the phenotypic susceptibility test in 50 %. Conclusions: qPCR has potential indication for early identification of pathogens and antimicrobial resistance genes from BSI in paediatric cancer patients and may improve antimicrobial therapy.Fundacao de Amparo a Pesquisa do estado de Sao Paulo (FAPESP) BrazilUniv Fed Sao Paulo, Inst Paediat Oncol, Rua Botucatu 743, BR-04037020 Sao Paulo, BrazilUniv Fed Sao Paulo, Div Infect Dis, Sao Paulo, BrazilUniv Fed Sao Paulo, Inst Paediat Oncol, Rua Botucatu 743, BR-04037020 Sao Paulo, BrazilUniv Fed Sao Paulo, Div Infect Dis, Sao Paulo, BrazilWeb of Science-engBiomed Central LtdClinical relevance of molecular identification of microorganisms and detection of antimicrobial resistance genes in bloodstream infections of paediatric cancer patientsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP11600/511282022-02-07 20:58:46.535metadata only accessoai:repositorio.unifesp.br:11600/51128Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestopendoar:34652022-02-07T23:58:46Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.en.fl_str_mv Clinical relevance of molecular identification of microorganisms and detection of antimicrobial resistance genes in bloodstream infections of paediatric cancer patients
title Clinical relevance of molecular identification of microorganisms and detection of antimicrobial resistance genes in bloodstream infections of paediatric cancer patients
spellingShingle Clinical relevance of molecular identification of microorganisms and detection of antimicrobial resistance genes in bloodstream infections of paediatric cancer patients
Carlesse, Fabianne [UNIFESP]
title_short Clinical relevance of molecular identification of microorganisms and detection of antimicrobial resistance genes in bloodstream infections of paediatric cancer patients
title_full Clinical relevance of molecular identification of microorganisms and detection of antimicrobial resistance genes in bloodstream infections of paediatric cancer patients
title_fullStr Clinical relevance of molecular identification of microorganisms and detection of antimicrobial resistance genes in bloodstream infections of paediatric cancer patients
title_full_unstemmed Clinical relevance of molecular identification of microorganisms and detection of antimicrobial resistance genes in bloodstream infections of paediatric cancer patients
title_sort Clinical relevance of molecular identification of microorganisms and detection of antimicrobial resistance genes in bloodstream infections of paediatric cancer patients
author Carlesse, Fabianne [UNIFESP]
author_facet Carlesse, Fabianne [UNIFESP]
Cappellano, Paola [UNIFESP]
Quiles, Milene Goncalves [UNIFESP]
Menezes, Liana Carballo [UNIFESP]
Petrilli, Antonio Sergio [UNIFESP]
Pignatari, Antonio Carlos [UNIFESP]
author_role author
author2 Cappellano, Paola [UNIFESP]
Quiles, Milene Goncalves [UNIFESP]
Menezes, Liana Carballo [UNIFESP]
Petrilli, Antonio Sergio [UNIFESP]
Pignatari, Antonio Carlos [UNIFESP]
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Carlesse, Fabianne [UNIFESP]
Cappellano, Paola [UNIFESP]
Quiles, Milene Goncalves [UNIFESP]
Menezes, Liana Carballo [UNIFESP]
Petrilli, Antonio Sergio [UNIFESP]
Pignatari, Antonio Carlos [UNIFESP]
description Background: Bloodstream infections (BSIs) are the major cause of mortality in cancer patients. Molecular techniques are used for rapid diagnosis of BSI, allowing early therapy and improving survival. We aimed to establish whether real-time quantitative polymerase chain reaction (qPCR) could improve early diagnosis and therapy in paediatric cancer patients, and describe the predominant pathogens of BSI and their antimicrobial susceptibility. Methods: Blood samples were processed by the BACTEC system and microbial identification and susceptibility tests were performed by the Phoenix system. All samples were screened by multiplex 16 s rDNA qPCR. Seventeen species were evaluated using sex-specific TaqMan probes and resistance genes blaSHV, blaTEM, blaCTX, blaKPC, blaIMP, blaSPM, blaVIM, vanA, vanB and mecA were screened by SYBR Green reactions. Therapeutic efficacy was evaluated at the time of positive blood culture and at final phenotypic identification and antimicrobial susceptibility results. Results: We analyzed 69 episodes of BSI from 64 patients. Gram-positive bacteria were identified in 61 % of the samples, Gram-negative bacteria in 32 % and fungi in 7 %. There was 78.2 % of agreement between the phenotypic and molecular methods in final species identification. The mecA gene was detected in 81.4 % of Staphylococcus spp., and 91.6 % were concordant with the phenotypic method. Detection of vanA gene was 100 % concordant. The concordance for Gram-negative susceptibilities was 71.4 % for Enterobacteriaceae and 50 % for Pseudomonas aeruginosa. Therapy was more frequently inadequate in patients who died, and the molecular test was concordant with the phenotypic susceptibility test in 50 %. Conclusions: qPCR has potential indication for early identification of pathogens and antimicrobial resistance genes from BSI in paediatric cancer patients and may improve antimicrobial therapy.
publishDate 2016
dc.date.issued.fl_str_mv 2016
dc.date.accessioned.fl_str_mv 2019-07-22T15:46:52Z
dc.date.available.fl_str_mv 2019-07-22T15:46:52Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv Bmc Infectious Diseases. London, v. 16, p. -, 2016.
dc.identifier.uri.fl_str_mv http://repositorio.unifesp.br/handle/11600/51128
http://dx.doi.org/10.1186/s12879-016-1792-8
dc.identifier.issn.none.fl_str_mv 1471-2334
dc.identifier.file.none.fl_str_mv WOS000382744900003.pdf
dc.identifier.doi.none.fl_str_mv 10.1186/s12879-016-1792-8
dc.identifier.wos.none.fl_str_mv WOS:000382744900003
identifier_str_mv Bmc Infectious Diseases. London, v. 16, p. -, 2016.
1471-2334
WOS000382744900003.pdf
10.1186/s12879-016-1792-8
WOS:000382744900003
url http://repositorio.unifesp.br/handle/11600/51128
http://dx.doi.org/10.1186/s12879-016-1792-8
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv -
dc.publisher.none.fl_str_mv Biomed Central Ltd
publisher.none.fl_str_mv Biomed Central Ltd
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv
_version_ 1802764130669559808